Results of a Multicenter Phase II Trial of Brentuximab Vedotin as Second-Line Therapy before Autologous Transplantation in Relapsed/Refractory Hodgkin Lymphoma
Titel:
Results of a Multicenter Phase II Trial of Brentuximab Vedotin as Second-Line Therapy before Autologous Transplantation in Relapsed/Refractory Hodgkin Lymphoma
Auteur:
Chen, Robert Palmer, Joycelynne M. Martin, Peter Tsai, Nicole Kim, Young Chen, Bihong T. Popplewell, Leslie Siddiqi, Tanya Thomas, Sandra H. Mott, Michelle Sahebi, Firoozeh Armenian, Saro Leonard, John Nademanee, Auayporn Forman, Stephen J.
Verschenen in:
Biology of blood and marrow transplantation
Paginering:
Jaargang 21 (2015) nr. 12 pagina's 5 p.
Jaar:
2015
Inhoud:
Uitgever:
American Society for Blood and Marrow Transplantation